Ipsen
Highly Engaged Employees
Manufacturing · France · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
65 Quai Georges Gorse, Boulogne-Billanco...Phone Number
+33 158335000Website
www.ipsen.comRevenue
$4.4 BillionStock Symbol
IPNIndustry
About Ipsen
Ipsen Org Chart
Is Ipsen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Ipsen is spiking on competitors!
Funding: Get notified immidiatlly once Ipsen has new funding data
Ipsen, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ipsen has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Ipsen had a recent Job posting/layoffs
Product Launch: Get notified when Ipsen launches new products
Earning: See what the market has to say on Ipsen recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ipsen
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Ipsen
Find 3 more new buyers
Company Profile Activity
Activity Insights
Ipsen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ipsen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ipsen.
Ipsen Tech Stack
A closer look at the technologies used by Ipsen
Most Recent Scoops
Ipsen News & Media
Three Reputable Industrial Atmospheric Furnace Manufacturers in China 2026: Advancing High-Temperature Processing
Focus on Stable Thermal Performance and Industrial Heat Treatment Applications CALIFORNIA, CA, UNITED STATES, June 8, 2026 /EINPresswire.com/ -- China, June 8, 2026—As global demand for precision heat treatment grows, three Chinese industrial …Ipsen announces the launch of an Employee Shareholding Plan
Ipsen announces the launch of an employee shareholding planNew late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC
PARIS, FRANCE, 28 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of new late-breaking results from the ELATIVE® Phase III trial and two real-world studies at the European Association for the Study of the Liver (EASL) congress. Together, these data further strengthen the growing body of evidence establishing IQIRVO® as the only second-line primary biliary cholangitis (PBC) treatment providing rapid and robust alkaline phosphatase (ALP) reduction with fatigue improveIpsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
PARIS, FRANCE – 19 MAY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today results from the only prospective, head-to-head Phase IV DIRECTION trial comparing Dysport® (abobotulinumtoxinA) to Botox® (onabotulinumtoxinA) in adults living with upper limb spasticity (ULS)1 will be presented as a late-breaking presentation at the International Society of Physical and Rehabilitation Medicine (ISPRM) world congress in Vancouver on May 19, 2026. The trial showed that patients treated with Dysport h
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ipsen
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.... Read More